Opening book details…
About this Medicine article
Phase II Study of Bevacizumab in Combination with Trastuzumab and Capecitabine as First-Line Treatment for HER-2-positive Locally Recurrent or Metastatic Breast Cancer by Martin, M.; Makhson, A.; Gligorov, J.; Lichinitser, M.; Lluch, A.; Semiglazov, V.; Scotto, N.; Mitchell, L.; Tjulandin, S. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Martin, M.; Makhson, A.; Gligorov, J.; Lichinitser, M.; Lluch, A.; Semiglazov, V.; Scotto, N.; Mitchell, L.; Tjulandin, S.
- Publisher
- Alphamed Press; AlphaMed Press Inc; Wiley (ISSN 1083-7159)
- Published
- 2012
- Field
- Medicine (Health Sciences)